Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repairdeficient/microsatellite instability-high metastatic colorectal cancer - Overman, M J; Lonardi, S; Wong, K YM (J Clin Oncol, 2018)
. doi:10.1200/JCO.2017.76.9901